Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 699,332
  • Shares Outstanding, K 122,475
  • Annual Sales, $ 113,310 K
  • Annual Income, $ -57,510 K
  • 60-Month Beta -1.13
  • Price/Sales 6.58
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade WVE with:

Options Overview Details

View History
  • Implied Volatility 94.96% ( -21.64%)
  • Historical Volatility 66.03%
  • IV Percentile 61%
  • IV Rank 38.03%
  • IV High 195.68% on 07/18/24
  • IV Low 33.14% on 05/20/24
  • Put/Call Vol Ratio 0.41
  • Today's Volume 660
  • Volume Avg (30-Day) 180
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 5,463
  • Open Int (30-Day) 3,803

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.27
  • Number of Estimates 5
  • High Estimate -0.22
  • Low Estimate -0.39
  • Prior Year 0.07
  • Growth Rate Est. (year over year) -485.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.04 +8.53%
on 09/06/24
6.15 -11.06%
on 09/09/24
-0.21 (-3.70%)
since 08/16/24
3-Month
4.25 +28.71%
on 06/27/24
6.86 -20.20%
on 07/31/24
-0.24 (-4.20%)
since 06/18/24
52-Week
3.50 +56.29%
on 02/14/24
7.67 -28.68%
on 03/07/24
+0.45 (+8.96%)
since 09/18/23

Most Recent Stories

More News
Wave Life Sciences: Q2 Earnings Snapshot

Wave Life Sciences: Q2 Earnings Snapshot

WVE : 5.47 (-4.20%)
2 Cutting-Edge Gene-Editing Stocks That You Don't Want to Miss

The gene-editing market is moving fast, and it pays to get to know some of these companies.

WVE : 5.47 (-4.20%)
BEAM : 25.51 (-0.27%)
Why Wave Life Sciences Was Zooming Higher Today

The company says it has enough dosh on hand to carry it through this and next year.

WVE : 5.47 (-4.20%)
Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

WVE-006 announced as investigational development candidate for AATD with CTA submissions expected in 2023; first-in-class RNA editing candidate and most...

WVE : 5.47 (-4.20%)
Wave Life Sciences to Webcast Conference Call of Second Quarter 2022 Financial Results on August 11, 2022

CAMBRIDGE, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to...

WVE : 5.47 (-4.20%)
Wave Life Sciences to Present at the 2022 Jefferies Healthcare Conference

CAMBRIDGE, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to...

WVE : 5.47 (-4.20%)
Wave Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update

Delivered first clinical data demonstrating target engagement and translation of PN chemistry’s impact in clinic; Adapting ongoing Phase 1b/2a FOCUS-C9...

WVE : 5.47 (-4.20%)
Wave Life Sciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to...

WVE : 5.47 (-4.20%)
Wave Life Sciences Announces Publication of Foundational Preclinical Data Supporting Development of WVE-004 for C9orf72-associated ALS and FTD

Preclinical data published in Molecular Therapy Nucleic Acids demonstrate that WVE-004 potently reduces C9orf72 transcriptional variants and poly(GP)...

WVE : 5.47 (-4.20%)
Wave Life Sciences to Present at Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

CAMBRIDGE, Mass., April 19, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to...

WVE : 5.47 (-4.20%)

Business Summary

WAVE Life Sciences Pte. Ltd. is a preclinical biopharmaceutical company. It designs, develops and commercializes nucleic acid therapeutic candidates for Huntington's disease, Duchenne muscular dystrophy and inflammatory bowel disease. Huntington's disease, the Company has programs targeting HTT SNP-1...

See More

Key Turning Points

3rd Resistance Point 5.92
2nd Resistance Point 5.83
1st Resistance Point 5.65
Last Price 5.47
1st Support Level 5.38
2nd Support Level 5.29
3rd Support Level 5.11

See More

52-Week High 7.67
Fibonacci 61.8% 6.08
Fibonacci 50% 5.59
Last Price 5.47
Fibonacci 38.2% 5.09
52-Week Low 3.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar